The need to diagnose bacterial meningitis as quickly as possible has led to the use of rapid diagnostic techniques that detect bacterial products in cerebrospinal fluid (CSF). Counterimmunoelectrophoresis (CIE) has been used to detect in CSF the soluble polysaccharide antigens of Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae, group B Streptococcus, and Escherichia coli Kl (5, 11, 15, 16, 18, 27) . Several investigators studied the sensitivity of CIE and emphasized the necessity of using antisera with high titers of precipitating antibodies (5, 7, 41) . The positivity rates by CIE of 779 CSF specimens from patients with meningococcal, pneumococcal, or H. influenzae meningitis were 75, 79, and 84%, respectively (4-6, 8, 11, 15, 16, 19, 30, 31, 39, 40-42) . The specificity of the technique was also studied, and some cross-reactions were reported (17, 33) . Such cross-reactions are not surprising because some of the organisms are known to have antigenic similarities (3, 14, 29, 35, 37) .
Our study was designed to explore the problems that might occur when reference and commercial antisera are used to detect antigens of organisms causing bacterial meningitis. Al antisera are currently prepared or evaluated specifically for use in CIE. We hoped that any crossreactions observed in our study might serve as a caveat to laboratorians using CIE to help establish a diagnosis of bacterial meningitis. Moreover, since interest in determining serological groups or types for epidemiological purposes has increased, these findings may have some bearing on the use of CIE for grouping or typing isolates of these organisms.
MATERIALS AND METHODS
Bacterial strains and antisera. Representative stock strains of each of the following bacteria, obtained from culture collections at the Center for Disease Control, Atlanta, Ga., and retested for purity and correct identity, were used to evaluate the specificity of 76 antisera for CIE testing: group B Streptococcus types Ia (strain 090), Ib (H36B), Ic (A909), II (18RS21), and III (D136C); S. pneumoniae types 1 (SP1), 3 (SP43), 4 (SP4), 6 (SP73), 7 (SP70), 8 (SP46), 12 (SP12), 14 (SP14), 18 (SP18), 19 antisera, all antisera were produced in rabbits. Specificities and numbers of sources (in parentheses) were as follows: group B Streptococcus (three); S. pneumoniae types 1 (three), 2 (two), 3 (three), 4 (two), five (one), 6 (two), seven (two), 8 (two), 12 (one), 14 (two), 18 (two), 19 (two), 22 (one) , and 23 (one); S. pneumoniae polyvalent (one); H. influenzae types a (four), b (four), c (four), d (four), e (four), and f (four); H. influenzae polyvalent (one); N. meningitidis groups A (three), B (four), C (three), D (two), X (two), Y (three), and Z (two); N. meningitidis polyvalent for groups A, B, C, and D (one); and N. meningitidis polyvalent for groups X, Y, and Z (one).
Antigen preparation. Frozen blood suspensions of the organisms were allowed to thaw and then were transferred to a suitable growth medium: 5 ml of ToddHewitt broth supplemented with 0.5 ml of defibrinated rabbit blood for streptococci and pneumoccocci; 5 ml of heart infusion broth supplemented with 0.5 ml of defibrinated rabbit blood for S. aureus, L. monocytogenes, and E. coli; 5 ml of heart infusion broth supplemented with 2 Both intraspecies and intergeneric cross-reactions were observed with pneumococcal antisera and will be described below. One pneumococcal type 7 antiserum reacted with uninoculated Todd-Hewitt broth and heart infusion broth and with every strain grown in either of these two broths. When strains were grown in alternate broths, no precipitation lines were observed, suggesting that the antiserum had reacted with components of Todd-Hewitt broth and heart infusion broth in the original tests.
It was of interest that pneumococcal type 7 and 14 antisera reacted with their homologous strains, because these capsular antigens are reportedly neutral (2) . With Center for Disease Control type 7 and 14 antisera, precipitation lines were observed very close to the antigen wells, which implies that antigen had diffused passively into the medium; in addition, a centrally located line occurred between the type 14 antiserum and its homologous strain.
As indicated above, numerous intraspecies and intergeneric cross-reactions were observed in the present study. These have been summarized in Tables 1 and 2 ingitidis group A by one set of antisera, and both group B meningococcal strains would just as likely have been identified as N. meningitidis group D by another set of antisera.
Many intraspecies cross-reactions were observed among pneumococcal antisera and strains. By paying close attention to the intensity and rapidity with which precipitation lines formed, it would have been possible to identify most pneumococcal strains correctly by their reactions with type-specific antisera; several strains, however, would have been identified incorrectly. With one set of antisera, S. pneumoniae types 7 and 12 probably would have been identified as type 3, and with another set of antisera types 7, 12, 14, 22 and 23 probably would have been identified as type 2. The latter reactions are included in Table 1 .
Intergeneric cross-reactions observed in the present study are shown in Table 2 . Among the most notable of these were reactions between an N. meningitidis group B and E. coli strains 07: K1:NM, 013:K92:H4, and 073:K92:H34, between an H. influenzae type b antiserum and an S. aureus strain, and between an S. pneumoniae type 19 antiserum and H. influenzae type a. CSF, according to published reports (9, 10). However, the concentration of soluble antigen in CSF of a patient might not be reflected accurately by the bacterial count, particularly if the clinical course has been lengthy. High concentrations of organisms were chosen in the present study to reveal the greatest number of cross-reactions that might occur.
The necessity of testing the sensitivity of antisera was emphasized by the failure of some monospecific antisera to react with homologous strains within 8 h after electrophoresis. Because either antigen excess or antibody excess is possible in tests with CSF or broth cultures, the testing of twofold dilutions of either or both reactants should be considered. One group B meningococcal antiserum did not produce precipitation lines with either of two group B meningococcal strains tested, even after overnight incubation at 4°C. Problems with group B meningococcal antisera were observed by others. In 1972, Tobin and Jones (41) reported that commercial group B meningococcal antisera detected no antigen by CIE in 22 clinical CSF specimens, 10 of which yielded N. meningitidis group B in culture. More recently, Ghanassia et al. (12) reported that no specific precipitation lines were observed with 28 CSF specimens that were culture positive for N. meningitidis group B.
The H. influenzae polyvalent antiserum did not appear to be adequate for detecting all of the type-specific H. influenzae antigens. If an H. influenzae polyvalent antiserum is to be relied on, it must have a high titer of precipitating antibodies to H. influenzae type b, because type b is the principal cause of bacterial meningitis in children between the ages of 1 month and 3 years in the United States (38) .
It is interesting that a meningococcal polyvalent antiserum for groups A, B, C, and D reacted with antigen in broth cultures of group B strains, whereas the monospecific antiserum for group B meningococcal antigen from this company failed to do so. It appears that the titer of precipitating antibodies to group B polysaccharide antigen was higher in the polyvalent antiserum than in the monospecific antiserum.
Several intraspecies and intergeneric cross-reactions were noted in the present study. The cross-reactions may be explained by one or more of the following: (i) immunochemically similar type or group capsular antigens that are bound loosely to the bacterial cell surface; (ii) similar noncapsular antigens that are released into the media during growth or by lysis of the organisms; (iii) broth constituents in the suspending medium that are chemically similar to bacterial antigens; and (iv) broth constituents which are inadvertently present in vaccine preparations and which serve as antigens during antiserum production.
The first possibility may be supported in some instances by proposed structural similarities ( Table 3 ). The observed cross-reactions of N. meningitidis groups B and C with E. coli strains Kl and K92, respectively, may have been due to common N-acetylneuraminic acid determinants in the former and common sialic acid determinants in the latter. Similarly, the cross-reactions between an H. influenzae type b antiserum and an S. aureus strain most likely occurred because 10, 1979 of common polyribitol phosphate determinants. Also listed in Table 3 , but not tested in this study, are reported cross-reactions between several other E. coli capsular types and pneumococcal types 1 and 3 and H. influenzae type b. Some of the observed or expected cross-reactions have been described in clinical situations. Investigation of the antigenic relationship between N. meningitidis group B and E. coli 07: K1(L):NM was begun after a bacterial strain isolated from the CSF of an infant with meningitis was identified as N. meningitidis group B and then later found to be E. coli 07:K1(L):NM (14) . Group B meningococcal antiserum has been used to detect E. coli Kl antigen in CSF and serum of neonates with meningitis (34). In another case, H. influenzae type b antiserum reacted with antigen in the CSF of a patient with S. aureus endocarditis (33) .
Intraspecies cross-reactions may also be explained by antigenic similarities. For example, group A meningococcal polysaccharide is a polymer of N-acetyl, 0-acetylmannosamine phosphate (25) , group B polysaccharide consists mainly of N-acetylneuraminic acid, and group C polysaccharide consists mainly of N-acetyl, 0-acetylneuraminic acid (24 Similarly, the type antigens of H. influenzae types a, b, c, and f have a common structural feature consisting of (1-l)-linked disaccharide subunits bridged by phosphodiester groups (43) ; the type d antigen is a polysaccharide that does not contain phosphorus or sulfur (1) . In addition, all of the types possess a common protein antigen (28); this so-called M substance is a labile surface antigen (20) . Many of the cross-reactions among the pneumococcal antisera and strains may have been due to similar type-specific polysaccharide antigens or, in support of the second possibility mentioned above, they may have been due to common noncapsular antigens. A cell wall carbohydrate antigen, known as "C substance," occurs within all types of the species (26) .
The possibility that an antiserum might react with broth constituents present in the suspend-CIE AND BACTERIAL MENINGITIS 523 ing medium may account for the cross-reactions observed with a pneumococcal type 7 antiserum and, perhaps, with two of the group B streptococcal antisera. Such reactions emphasize the importance of including medium controls in CIE tests when the antigens are suspended in media.
Precautions such as the following must be taken when CIE is being used to help in the identification of organisms causing bacterial meningitis: (i) antisera must always be tested for sensitivity and specificity; (ii) antigen controls should be included in CIE tests regularly; (iii) uninoculated broth (medium) controls should be used to test the specificity of antisera if CIE is being used as a grouping or typing technique for organisms grown in broth or harvested in medium; and (iv) because of potential serological cross-reactivity, culture and microscopy data should be used in interpreting positive CIE results.
In conclusion, if properly performed and interpreted, CIE may be a valuable adjunct in the identification of organisms causing bacterial meningitis, but it should not be used to replace the Gram stain and culture techniques.
